We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DIXON:NSEDixon Technologies (India) Ltd. Analysis

Data as of 2026-03-14 - not real-time

₹10,338.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Dixon Technologies is trading at INR 10,338, well below its 20‑day SMA of 10,689, indicating short‑term weakness. The 50‑day SMA (11,010) and 200‑day SMA (14,479) remain higher, confirming a bearish medium‑term bias. RSI sits at 44, suggesting the stock is not yet oversold but lacks bullish momentum. MACD has turned positive with the histogram at +39, offering a tentative bullish signal amid the overall bearish trend. Volume is increasing, and the price is testing the support at INR 9,630, while resistance lies near INR 11,839.
The company posted a modest 2.1% YoY revenue growth to ₹10,678 crore in Q3 FY26, with EBITDA up 5.8% to ₹421 crore. However, EPS forecasts have been trimmed by 6‑16% for FY26‑28, reflecting uncertainty around future earnings expansion. Valuation is stretched at a forward P/E of 50.6 versus the industry average of 33.7, and the price‑to‑book of 13.8 further underscores premium pricing. Dividend yield is low at 0.08% with a payout ratio of just 3%, raising questions about dividend sustainability. The stock’s beta of –0.22 points to low market correlation, but 30‑day volatility exceeds 53%, indicating sharp price swings. The fear‑greed index reading of “Greed” (72.9) suggests market optimism may be overstated. Given the blend of technical resilience, modest top‑line growth, and elevated valuation, the upside potential is limited to roughly 27% while downside risk remains significant.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price near key support level
  • bearish SMA hierarchy
  • high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • modest revenue and EBITDA growth
  • valuation premium relative to peers
  • recent EPS estimate cuts

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • diversified product portfolio and export exposure
  • low beta indicating limited market correlation
  • potential for long‑term industry tailwinds

Key Metrics & Analysis

Financial Health

Revenue Growth2.10%
Profit Margin3.25%
P/E Ratio37.6
Debt/Equity29.66
P/B Ratio13.8
Industry P/E33.7

Technical Analysis

TrendBearish
RSI44.4
Support₹9,630.00
Resistance₹11,839.00
MA 20₹10,689.90
MA 50₹11,010.16
MA 200₹14,478.80
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price₹13,114.41
Upside/Downside26.86%
GradeOvervalued
TypeBlend
Dividend Yield0.08%

Risk Assessment

Beta-0.22
Volatility53.21%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.